CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 54 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,860 | -22.3% | 5,586 | 0.0% | 0.00% | – |
| Q2 2023 | $6,256 | +7.7% | 5,586 | 0.0% | 0.00% | – |
| Q1 2023 | $5,809 | -7.1% | 5,586 | 0.0% | 0.00% | – |
| Q4 2022 | $6,256 | +4.3% | 5,586 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -25.0% | 5,586 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -38.5% | 5,586 | 0.0% | 0.00% | – |
| Q1 2022 | $13,000 | -13.3% | 5,586 | 0.0% | 0.00% | – |
| Q4 2021 | $15,000 | -55.9% | 5,586 | 0.0% | 0.00% | – |
| Q3 2021 | $34,000 | +25.9% | 5,586 | 0.0% | 0.00% | – |
| Q2 2021 | $27,000 | +92.9% | 5,586 | 0.0% | 0.00% | – |
| Q1 2021 | $14,000 | -6.7% | 5,586 | 0.0% | 0.00% | – |
| Q4 2020 | $15,000 | +66.7% | 5,586 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | -30.8% | 5,586 | +365.5% | 0.00% | – |
| Q2 2018 | $13,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
| BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
| Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
| WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
| Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
| XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
| Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
| SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |